These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37914023)

  • 1. Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions.
    Fukunaga K; Tsukagoshi E; Kurata M; Mizukawa Y; Niihara H; Morita E; Watanabe Y; Yamaguchi Y; Watanabe H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Azukizawa H; Asada H; Hasegawa A; Hama N; Ozeki T; Mashimo Y; Sekine A; Matsunaga K; Tanaka Y; Nakamura R; Abe R; Mushiroda T; Saito Y
    J Invest Dermatol; 2024 Apr; 144(4):908-911.e7. PubMed ID: 37914023
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.
    Wang Q; Zhou JQ; Zhou LM; Chen ZY; Fang ZY; Chen SD; Yang LB; Cai XD; Dai QL; Hong H; Wang HX
    Seizure; 2011 Jul; 20(6):446-8. PubMed ID: 21397523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine cutaneous adverse reactions and
    Meng Q; Gu H; Zhang Q; Yi Z; Jiang D
    Pharmacogenomics; 2023 Jun; 24(8):459-474. PubMed ID: 37503628
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Capule F; Tragulpiankit P; Mahasirimongkol S; Jittikoon J; Wichukchinda N; Alentajan-Aleta LT; Barit JJ; Casanova-Gutierrez J; Cabral-Lim L; Baltazar Reyes JP; Roa F; Salonga R; San Gabriel KF; Silao CL
    Pharmacogenomics; 2021 Jun; 22(8):465-472. PubMed ID: 33910375
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carbamazepine induced Stevens-Johnson syndrome in Han Chinese with positive
    Xu YY; Sun ZL; Zhang XL; Liu ZL; Liu W; Guan X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):755-757. PubMed ID: 37534663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.
    Nakkam N; Konyoung P; Amornpinyo W; Saksit N; Tiamkao S; Khunarkornsiri U; Khaeso K; Pattanacheewapull O; Jorns TP; Chumworathayi P; Tassaneeyakul W
    Br J Clin Pharmacol; 2022 Feb; 88(2):773-786. PubMed ID: 34350628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B*1502 screening and toxic effects of carbamazepine.
    Phillips EJ; Mallal SA
    N Engl J Med; 2011 Aug; 365(7):672; author reply 673. PubMed ID: 21848472
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA-B*1502 screening and toxic effects of carbamazepine.
    Liao WP; Shi YW; Min FL
    N Engl J Med; 2011 Aug; 365(7):672-3; author reply 673. PubMed ID: 21848471
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population.
    Mortazavi H; Rostami A; Firooz A; Esmaili N; Ghiasi M; Lajevardi V; Amirzargar AA; Sheykhi I; Khamesipour A; Akhdar M
    Dermatol Ther; 2022 May; 35(5):e15393. PubMed ID: 35187767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
    Sukasem C; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Sririttha S; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Puangpetch A; Aekplakorn W
    J Immunol Res; 2018; 2018():2780272. PubMed ID: 29546073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
    Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
    Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.
    Nguyen DV; Vidal C; Chi HC; Do NTQ; Fulton R; Li J; Fernando SL
    HLA; 2017 Dec; 90(6):335-342. PubMed ID: 28884973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A*31: 01 and HLA-B*15:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population.
    Khor AH; Lim KS; Tan CT; Kwan Z; Tan WC; Wu DB; Ng CC
    Pharmacogenet Genomics; 2017 Jul; 27(7):275-278. PubMed ID: 28570299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.
    Mehta TY; Prajapati LM; Mittal B; Joshi CG; Sheth JJ; Patel DB; Dave DM; Goyal RK
    Indian J Dermatol Venereol Leprol; 2009; 75(6):579-82. PubMed ID: 19915237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
    Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH;
    Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
    Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
    Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
    Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
    Epilepsia; 2010 Dec; 51(12):2461-5. PubMed ID: 21204807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.
    Nicoletti P; Barrett S; McEvoy L; Daly AK; Aithal G; Lucena MI; Andrade RJ; Wadelius M; Hallberg P; Stephens C; Bjornsson ES; Friedmann P; Kainu K; Laitinen T; Marson A; Molokhia M; Phillips E; Pichler W; Romano A; Shear N; Sills G; Tanno LK; Swale A; Floratos A; Shen Y; Nelson MR; Watkins PB; Daly MJ; Morris AP; Alfirevic A; Pirmohamed M
    Clin Pharmacol Ther; 2019 Nov; 106(5):1028-1036. PubMed ID: 31066027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese.
    van Nguyen D; Chu HC; Vidal C; Fulton RB; Nguyen NN; Quynh Do NT; Tran TL; Nguyen TN; Thu Nguyen HT; Chu HH; Thanh Thuc HT; Minh Le HT; van Nunen S; Anderson J; Fernando SL
    Pharmacogenomics; 2021 Jan; 22(1):1-12. PubMed ID: 33356553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.